Membership
Tour
Register
Log in
Remko VAN DER VLUGT
Follow
Person
Zoetermeer, NL
People
Overview
Industries
Organizations
People
Information
Impact
Patents Grants
last 30 patents
Information
Patent Grant
Potent and short promoter for expression of heterologous genes
Patent number
12,054,737
Issue date
Aug 6, 2024
Janssen Vaccines & Prevention B.V.
Kerstin Wunderlich
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Potent and short promoter for expression of heterologous genes
Patent number
11,034,978
Issue date
Jun 15, 2021
Janssen Vaccines & Prevention B.V.
Kerstin Wunderlich
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information
Patent Grant
Human neutralizing antibodies binding to influenza B neuraminidase
Patent number
10,703,803
Issue date
Jul 7, 2020
Janssen Vaccines & Prevention B.V.
Miriam Verena Bujny
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Human neutralizing antibodies binding to influenza neuraminidase
Patent number
10,174,127
Issue date
Jan 8, 2019
Janssen Vaccines & Prevention B.V.
Miriam Verena Bujny
C07 - ORGANIC CHEMISTRY
Patents Applications
last 30 patents
Information
Patent Application
POTENT AND SHORT PROMOTER FOR EXPRESSION OF HETEROLOGOUS GENES
Publication number
20210261984
Publication date
Aug 26, 2021
Janssen Vaccines & Prevention B.V.
Kerstin WUNDERLICH
C07 - ORGANIC CHEMISTRY
Information
Patent Application
HUMAN NEUTRALIZING ANTIBODIES BINDING TO INFLUENZA B NEURAMINIDASE
Publication number
20200002406
Publication date
Jan 2, 2020
Janssen Vaccines & Prevention B.V.
Miriam Verena BUJNY
C07 - ORGANIC CHEMISTRY
Information
Patent Application
POTENT AND SHORT PROMOTER FOR EXPRESSION OF HETEROLOGOUS GENES
Publication number
20180223314
Publication date
Aug 9, 2018
Janssen Vaccines & Prevention B.V.
Kerstin WUNDERLICH
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information
Patent Application
HUMAN NEUTRALIZING ANTIBODIES BINDING TO INFLUENZA NEURAMINIDASE
Publication number
20180016348
Publication date
Jan 18, 2018
Janssen Vaccines & Prevention B.V.
Miriam Verena BUJNY
G01 - MEASURING TESTING